Reset all filters
01 3NOVARTIS
Reset all filters
01 1CAPSULE;ORAL
02 1TABLET, FOR SUSPENSION;ORAL
03 1TABLET; ORAL SUSPENSION
Reset all filters
01 1RX
02 2Blank
Reset all filters
01 3TAFINLAR
01 1Yes
02 2Blank
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code :
Novartis Pharmaceuticals Corporation
Dosage Form : TABLET, FOR SUSPENSION; ORAL
Proprietary Name : TAFINLAR
Dosage Strength : EQ 10MG BASE
Approval Date : 2023-03-16
Application Number : 217514
RX/OTC/DISCN : RX
RLD : Yes
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD :
TE Code :
Novartis Pharmaceuticals Corporation
Dosage Form : CAPSULE; ORAL
Proprietary Name : TAFINLAR
Dosage Strength : 75MG
Approval Date :
Application Number : 217514
RX/OTC/DISCN :
RLD :
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD :
TE Code :
Novartis Pharmaceuticals Corporation
Dosage Form : TABLET; ORAL SUSPENSION
Proprietary Name : TAFINLAR
Dosage Strength : 10MG
Approval Date :
Application Number : 217514
RX/OTC/DISCN :
RLD :
TE Code :
